CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed range.

The cancer company plans to sell 186.4 million shares at HK$11.10-HK$12.80 on the Hong Kong stock exchange. At the HK$11.95 midpoint, CStone would raise HK$2.2 billion ($283.8 million)...